The weekly litigation news digest is live. Subscribe now

Combined Pharmaceutical Composition

Patent No. EP3030262 (titled "Combined Pharmaceutical Composition") was filed by Cytune Pharma on Aug 8, 2014. The application was issued on Oct 9, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONJul 9, 2020MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3030262

CYTUNE PHARMA
Application Number
EP14761281A
Filing Date
Aug 8, 2014
Status
Opposition Rejected
Feb 24, 2023
Publication Date
Oct 9, 2019
External Links
Slate, Register, Google Patents